CANIVERM 0.7 g, comprimate
CANIVERM 0.7 g, comprimate
Authorised
- Praziquantel
- Pyrantel embonate
- Fenbendazole
Product identification
Medicine name:
CANIVERM 0.7 g, comprimate
Active substance:
- Praziquantel
- Pyrantel embonate
- Fenbendazole
Target species:
-
Dog
-
Raccoon dog
-
Cat
-
Bobcat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Fenbendazole150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 150215
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 6/12/2021